(Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 82.18%-22.18K | -6.51%-75.19K | 14.61%-105.01K | 39.47%-423.59K | 46.71%-105.59K | 12.17%-124.44K | 66.74%-70.59K | 16.76%-122.97K | -55.10%-699.77K | 23.92%-198.15K |
Net income from continuing operations | 15.73%-88.19K | 50.87%-92.5K | 6.97%-158.3K | 40.39%-591.27K | 45.49%-128.19K | 70.68%-104.66K | -12.14%-188.27K | 26.61%-170.16K | -78.71%-991.86K | -9.16%-235.19K |
Operating gains losses | ---- | --3.5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Asset impairment expenditure | ---- | ---- | ---- | --11K | ---- | ---- | ---- | ---- | --0 | ---- |
Remuneration paid in stock | --0 | --0 | --0 | -67.52%66.85K | -105.61%-1.97K | -99.24%1.3K | --33.73K | --33.79K | --205.84K | --35.09K |
Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---1.5K | ---- | ---- | ---- |
Change In working capital | 413.11%66.02K | -83.83%13.81K | 297.84%53.29K | 4.14%89.83K | 522.49%12.07K | -147.36%-21.08K | 292.77%85.45K | -84.08%13.4K | 588.43%86.25K | 104.31%1.94K |
-Change in receivables | 21.78%1.45K | -497.85%-6.1K | 251.69%8.31K | -102.69%-655 | 124.60%2.1K | 159.14%1.19K | -73.52%1.53K | -127.84%-5.48K | 156.09%24.39K | 104.65%935 |
-Change in prepaid assets | 109.45%1.93K | -39.38%9.03K | 118.96%22.57K | -62.42%2.61K | 81.78%-2.15K | -385.63%-20.44K | 234.95%14.89K | 44.08%10.31K | 115.72%6.94K | 69.08%-11.81K |
-Change in payables and accrued expense | 3,507.51%62.63K | -84.23%10.89K | 161.52%22.41K | 60.01%87.87K | -5.43%12.12K | -104.67%-1.84K | 226.50%69.02K | -85.04%8.57K | -21.53%54.92K | -3.73%12.82K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 82.18%-22.18K | -6.51%-75.19K | 14.61%-105.01K | 39.47%-423.59K | 46.71%-105.59K | 12.17%-124.44K | 66.74%-70.59K | 16.76%-122.97K | -55.10%-699.77K | 23.92%-198.15K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 16.67%-25K | -910 | -30.6K | -600 | 0 | -30K | 0 | 0 | 0 |
Net PPE purchase and sale | --0 | 16.67%-25K | ---910 | ---30.6K | ---600 | --0 | ---30K | --0 | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | 16.67%-25K | ---910 | ---30.6K | ---600 | --0 | ---30K | --0 | --0 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Cash from discontinued financing activities | ||||||||||
Net cash flow | ||||||||||
Beginning cash position | -93.65%29.6K | -77.11%129.78K | -65.84%235.7K | -50.36%689.89K | -61.50%341.89K | -54.71%466.33K | -54.35%566.92K | -50.36%689.89K | --1.39M | -46.18%888.04K |
Current changes in cash | 82.18%-22.18K | 0.40%-100.19K | 13.87%-105.92K | 35.09%-454.19K | 46.41%-106.19K | 12.17%-124.44K | 52.60%-100.59K | 16.76%-122.97K | -150.36%-699.77K | 23.92%-198.15K |
End cash Position | -97.83%7.42K | -93.65%29.6K | -77.11%129.78K | -65.84%235.7K | -65.84%235.7K | -61.50%341.89K | -54.71%466.33K | -54.35%566.92K | -50.36%689.89K | -50.36%689.89K |
Free cash from | 82.18%-22.18K | 0.40%-100.19K | 13.87%-105.92K | 35.09%-454.19K | 46.41%-106.19K | 12.17%-124.44K | 52.60%-100.59K | 16.76%-122.97K | -55.10%-699.77K | 23.92%-198.15K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.